Nature de la demande
Réévaluation du SMR
Service Médical Rendu (SMR)
| Faible |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
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
2XJ6vA7QChvGu7nJ